PortfoliosLab logoPortfoliosLab logo
NRO.PA vs. AFYA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NRO.PA vs. AFYA - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Neurones S.A. (NRO.PA) and Afya Limited (AFYA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

NRO.PA is traded in EUR, while AFYA is traded in USD. To make them comparable, the AFYA values have been converted to EUR using the latest available exchange rates.

Returns By Period

In the year-to-date period, NRO.PA achieves a -9.41% return, which is significantly lower than AFYA's -1.86% return.


NRO.PA

1D
2.23%
1M
7.73%
YTD
-9.41%
6M
-12.36%
1Y
-14.93%
3Y*
1.98%
5Y*
8.48%
10Y*
9.62%

AFYA

1D
-1.38%
1M
3.48%
YTD
-1.86%
6M
-1.36%
1Y
-18.05%
3Y*
4.00%
5Y*
-8.40%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

NRO.PA vs. AFYA - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
NRO.PA
Neurones S.A.
-9.41%0.74%3.20%14.49%6.17%73.33%14.68%-9.25%
AFYA
Afya Limited
-1.86%-13.36%-22.81%36.19%5.59%-33.26%-14.40%14.02%

Correlation

The correlation between NRO.PA and AFYA is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.12

Correlation (3Y)
Calculated over the trailing 3-year period

0.07

Correlation (5Y)
Calculated over the trailing 5-year period

0.06

Correlation (All Time)
Calculated using the full available price history since Jul 22, 2019

0.05

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NRO.PA vs. AFYA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NRO.PA
NRO.PA Risk / Return Rank: 1919
Overall Rank
NRO.PA Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
NRO.PA Sortino Ratio Rank: 1616
Sortino Ratio Rank
NRO.PA Omega Ratio Rank: 1717
Omega Ratio Rank
NRO.PA Calmar Ratio Rank: 2424
Calmar Ratio Rank
NRO.PA Martin Ratio Rank: 2424
Martin Ratio Rank

AFYA
AFYA Risk / Return Rank: 1919
Overall Rank
AFYA Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
AFYA Sortino Ratio Rank: 1717
Sortino Ratio Rank
AFYA Omega Ratio Rank: 1717
Omega Ratio Rank
AFYA Calmar Ratio Rank: 2121
Calmar Ratio Rank
AFYA Martin Ratio Rank: 2424
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NRO.PA vs. AFYA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Neurones S.A. (NRO.PA) and Afya Limited (AFYA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NRO.PAAFYADifference
Sharpe ratioReturn per unit of total volatility

+0.06

Sortino ratioReturn per unit of downside risk

+0.06

Omega ratioGain probability vs. loss probability

0.92

0.91

+0.01

Calmar ratioReturn relative to maximum drawdown

-0.51

-0.61

+0.10

Martin ratioReturn relative to average drawdown

-0.88

-0.89

+0.02

NRO.PA vs. AFYA - Sharpe Ratio Comparison

The current NRO.PA Sharpe Ratio is -0.60, which is comparable to the AFYA Sharpe Ratio of -0.65. The chart below compares the historical Sharpe Ratios of NRO.PA and AFYA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


NRO.PAAFYADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.60

-0.65

+0.06

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.33

-0.21

+0.55

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.39

Sharpe Ratio (All Time)

Calculated using the full available price history

0.23

-0.15

+0.38

Drawdowns

NRO.PA vs. AFYA - Drawdown Comparison

The maximum NRO.PA drawdown since its inception was -77.55%, which is greater than AFYA's maximum drawdown of -69.16%. Use the drawdown chart below to compare losses from any high point for NRO.PA and AFYA.


Loading charts...

Drawdown Indicators


NRO.PAAFYADifference

Max Drawdown

Largest peak-to-trough decline

-77.55%

-69.16%

-8.39%

Max Drawdown (1Y)

Largest decline over 1 year

-29.16%

-29.67%

+0.51%

Max Drawdown (3Y)

Largest decline over 3 years

-32.28%

-44.08%

+11.80%

Max Drawdown (5Y)

Largest decline over 5 years

-32.28%

-61.49%

+29.21%

Max Drawdown (10Y)

Largest decline over 10 years

-40.74%

Current Drawdown

Current decline from peak

-21.51%

-55.24%

+33.73%

Average Drawdown

Average peak-to-trough decline

-24.12%

-43.66%

+19.54%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.92%

20.24%

-3.32%

Volatility

NRO.PA vs. AFYA - Volatility Comparison

The current volatility for Neurones S.A. (NRO.PA) is 6.35%, while Afya Limited (AFYA) has a volatility of 7.06%. This indicates that NRO.PA experiences smaller price fluctuations and is considered to be less risky than AFYA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NRO.PAAFYADifference

Volatility (1M)

Calculated over the trailing 1-month period

6.35%

7.06%

-0.71%

Volatility (6M)

Calculated over the trailing 6-month period

18.70%

21.40%

-2.70%

Volatility (1Y)

Calculated over the trailing 1-year period

24.80%

27.68%

-2.88%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.13%

39.63%

-14.50%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.41%

46.90%

-22.49%

Dividends

NRO.PA vs. AFYA - Dividend Comparison

NRO.PA's dividend yield for the trailing twelve months is around 3.33%, less than AFYA's 4.58% yield.


PositionTTM20252024202320222021202020192018201720162015
AFYA
Afya Limited
4.58%1.51%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
NRO.PA
Neurones S.A.
3.33%3.02%2.73%2.51%2.55%5.26%0.85%0.29%0.32%0.21%0.27%0.34%

Financials

NRO.PA vs. AFYA - Financials Comparison

This section allows you to compare key financial metrics between Neurones S.A. and Afya Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. NRO.PA values in EUR, AFYA values in USD

Frequently Asked Questions


NRO.PA and AFYA have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for NRO.PA and AFYA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer